Ever since the novel coronavirus outbreak, high-tech companies in China have been working overtime to make themselves central to the fight against time.
Global biopharmaceutical company UCB and China's e-commerce platform JD.com's health arm JD Health jointly launched on Friday a single-disease care platform on JD.com, to help epilepsy patients get access to services and medications they need, when it is difficult for them to visit hospitals due to the COVID-19 outbreak.
Service outsourcing companies, most of whom have resumed normal operations, have come up with software applications for corporate clients to remotely manage and ensure the health of employees.
